Rating History for CytomX Therapeutics (CTMX) by Guggenheim

More Stocks Rated by Guggenheim | Latest Ratings for CTMX
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
1/20/2026 Michael Sch New Coverage Buy
(N/A)		 10.00
(N/A)		 5.39
(4.68)		 -13.17% Details